These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37578200)

  • 1. Molecular mechanisms of alcohol's effects on the human body: A review and update.
    Renu K; Myakala H; Chakraborty R; Bhattacharya S; Abuwani A; Lokhandwala M; Vellingiri B; Gopalakrishnan AV
    J Biochem Mol Toxicol; 2023 Dec; 37(12):e23502. PubMed ID: 37578200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Esophageal variceal hemorrhage presenting as sudden death in outpatients.
    Tsokos M; Türk EE
    Arch Pathol Lab Med; 2002 Oct; 126(10):1197-200. PubMed ID: 12296758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbiota reprogramming for treatment of alcohol-related liver disease.
    Siddiqui MT; Cresci GAM
    Transl Res; 2020 Dec; 226():26-38. PubMed ID: 32687975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice.
    Ferrere G; Wrzosek L; Cailleux F; Turpin W; Puchois V; Spatz M; Ciocan D; Rainteau D; Humbert L; Hugot C; Gaudin F; Noordine ML; Robert V; Berrebi D; Thomas M; Naveau S; Perlemuter G; Cassard AM
    J Hepatol; 2017 Apr; 66(4):806-815. PubMed ID: 27890791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alcohol, liver disease and the gut microbiota.
    Bajaj JS
    Nat Rev Gastroenterol Hepatol; 2019 Apr; 16(4):235-246. PubMed ID: 30643227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Gastrointestinal Microbiome: Alcohol Effects on the Composition of Intestinal Microbiota.
    Engen PA; Green SJ; Voigt RM; Forsyth CB; Keshavarzian A
    Alcohol Res; 2015; 37(2):223-36. PubMed ID: 26695747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal dysbiosis and permeability: the yin and yang in alcohol dependence and alcoholic liver disease.
    Stärkel P; Leclercq S; de Timary P; Schnabl B
    Clin Sci (Lond); 2018 Jan; 132(2):199-212. PubMed ID: 29352076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbiome as a therapeutic target in alcohol-related liver disease.
    Sarin SK; Pande A; Schnabl B
    J Hepatol; 2019 Feb; 70(2):260-272. PubMed ID: 30658727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Gut Barrier, Intestinal Microbiota, and Liver Disease: Molecular Mechanisms and Strategies to Manage.
    Plaza-Díaz J; Solís-Urra P; Rodríguez-Rodríguez F; Olivares-Arancibia J; Navarro-Oliveros M; Abadía-Molina F; Álvarez-Mercado AI
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33171747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the gut microbiota to treat alcoholic liver diseases: evidence and promises.
    Leclercq S; de Timary P; Stärkel P
    Acta Gastroenterol Belg; 2020; 83(4):616-621. PubMed ID: 33321019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbiota, Liver Diseases, and Alcohol.
    Cassard AM; Gérard P; Perlemuter G
    Microbiol Spectr; 2017 Aug; 5(4):. PubMed ID: 28840806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alcohol consumption by cirrhotic subjects: patterns of use and effects on liver function.
    Lucey MR; Connor JT; Boyer TD; Henderson JM; Rikkers LF;
    Am J Gastroenterol; 2008 Jul; 103(7):1698-706. PubMed ID: 18494835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal permeability, microbial translocation, changes in duodenal and fecal microbiota, and their associations with alcoholic liver disease progression in humans.
    Maccioni L; Gao B; Leclercq S; Pirlot B; Horsmans Y; De Timary P; Leclercq I; Fouts D; Schnabl B; Stärkel P
    Gut Microbes; 2020 Nov; 12(1):1782157. PubMed ID: 32588725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alcohol's Impact on the Gut and Liver.
    Pohl K; Moodley P; Dhanda AD
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probiotics-Based Treatment as an Integral Approach for Alcohol Use Disorder in Alcoholic Liver Disease.
    Fuenzalida C; Dufeu MS; Poniachik J; Roblero JP; Valenzuela-Pérez L; Beltrán CJ
    Front Pharmacol; 2021; 12():729950. PubMed ID: 34630107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host Factors in Dysregulation of the Gut Barrier Function during Alcohol-Associated Liver Disease.
    Maccioni L; Leclercq IA; Schnabl B; Stärkel P
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alcohol Addiction, Gut Microbiota, and Alcoholism Treatment: A Review.
    Wang SC; Chen YC; Chen SJ; Lee CH; Cheng CM
    Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32899236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review article: Alcohol and gut microbiota - the possible role of gut microbiota modulation in the treatment of alcoholic liver disease.
    Vassallo G; Mirijello A; Ferrulli A; Antonelli M; Landolfi R; Gasbarrini A; Addolorato G
    Aliment Pharmacol Ther; 2015 May; 41(10):917-27. PubMed ID: 25809237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of gut bacterial and non-bacterial microbiota in alcohol-associated liver disease: Molecular mechanisms, biomarkers, and therapeutic prospective.
    Zafari N; Velayati M; Fahim M; Maftouh M; Pourali G; Khazaei M; Nassiri M; Hassanian SM; Ghayour-Mobarhan M; Ferns GA; Kiani MA; Avan A
    Life Sci; 2022 Sep; 305():120760. PubMed ID: 35787997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut Microbiome Dysbiosis in Alcoholism: Consequences for Health and Recovery.
    Day AW; Kumamoto CA
    Front Cell Infect Microbiol; 2022; 12():840164. PubMed ID: 35310839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.